Matches in SemOpenAlex for { <https://semopenalex.org/work/W1994296072> ?p ?o ?g. }
Showing items 1 to 77 of
77
with 100 items per page.
- W1994296072 endingPage "495" @default.
- W1994296072 startingPage "492" @default.
- W1994296072 abstract "wenty-two patients affected by relapsed or refractory nonHodgkin's lymphoma (NHL) were treated with a combination of ifosfamide (IFO) at the dose of 1.2 g/m2 intravenous (i.v.) (1 h infusion) for 5 consecutive days with mesna as uroprotector plus mitoxantrone (NOV) at the dose of 12 mg/ m2 i.v. on day 1; both drugs were recycled every 3–4 weeks. Of 21 evaluable patients, overall response observed was 57% (38% complete response and 19% partial response with a median duration of response of 7 months (5–23+). Dose-limiting toxicity was represented by leukopenia (grade III-IV in 43% of cases); severe thrombocytopenia was observed less frequently (grade III-IV in 19% of cases). This hematologic toxicity prevented administration of therapy every 3 weeks as initially planned. However, the complete hematological recovery, usually observed at the fourth week, permitted therapy administration to all patients without dose reduction. Lowgrade lymphomas responded to treatment as well as intermediate or high grade lymphomas. Moreover, patients treated with third- or fourth-line chemotherapy also responded. However, response was observed in 11/13 (85%) relapsed patients as compared to 2/8 (25%) refractory cases. The combination of IFO plus NOV is active in heavily pretreated patients with NHL. Nevertheless, the study of a larger number of patients is necessary to better define the exact role of this combination as “salvage” therapy for NHL." @default.
- W1994296072 created "2016-06-24" @default.
- W1994296072 creator A5051722602 @default.
- W1994296072 creator A5057828080 @default.
- W1994296072 creator A5085211609 @default.
- W1994296072 creator A5090055323 @default.
- W1994296072 creator A5090292355 @default.
- W1994296072 date "1991-12-01" @default.
- W1994296072 modified "2023-09-23" @default.
- W1994296072 title "Ifosfamide plus Mitoxantrone as Salvage Treatment in Non-Hodgkinʼs Lymphomas" @default.
- W1994296072 doi "https://doi.org/10.1097/00000421-199112000-00007" @default.
- W1994296072 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1957837" @default.
- W1994296072 hasPublicationYear "1991" @default.
- W1994296072 type Work @default.
- W1994296072 sameAs 1994296072 @default.
- W1994296072 citedByCount "12" @default.
- W1994296072 countsByYear W19942960722016 @default.
- W1994296072 crossrefType "journal-article" @default.
- W1994296072 hasAuthorship W1994296072A5051722602 @default.
- W1994296072 hasAuthorship W1994296072A5057828080 @default.
- W1994296072 hasAuthorship W1994296072A5085211609 @default.
- W1994296072 hasAuthorship W1994296072A5090055323 @default.
- W1994296072 hasAuthorship W1994296072A5090292355 @default.
- W1994296072 hasConcept C121332964 @default.
- W1994296072 hasConcept C126322002 @default.
- W1994296072 hasConcept C141071460 @default.
- W1994296072 hasConcept C142424586 @default.
- W1994296072 hasConcept C2776694085 @default.
- W1994296072 hasConcept C2777506904 @default.
- W1994296072 hasConcept C2778119113 @default.
- W1994296072 hasConcept C2779338263 @default.
- W1994296072 hasConcept C2780376820 @default.
- W1994296072 hasConcept C2780775027 @default.
- W1994296072 hasConcept C2780873365 @default.
- W1994296072 hasConcept C2780923524 @default.
- W1994296072 hasConcept C29730261 @default.
- W1994296072 hasConcept C71924100 @default.
- W1994296072 hasConcept C87355193 @default.
- W1994296072 hasConcept C90924648 @default.
- W1994296072 hasConceptScore W1994296072C121332964 @default.
- W1994296072 hasConceptScore W1994296072C126322002 @default.
- W1994296072 hasConceptScore W1994296072C141071460 @default.
- W1994296072 hasConceptScore W1994296072C142424586 @default.
- W1994296072 hasConceptScore W1994296072C2776694085 @default.
- W1994296072 hasConceptScore W1994296072C2777506904 @default.
- W1994296072 hasConceptScore W1994296072C2778119113 @default.
- W1994296072 hasConceptScore W1994296072C2779338263 @default.
- W1994296072 hasConceptScore W1994296072C2780376820 @default.
- W1994296072 hasConceptScore W1994296072C2780775027 @default.
- W1994296072 hasConceptScore W1994296072C2780873365 @default.
- W1994296072 hasConceptScore W1994296072C2780923524 @default.
- W1994296072 hasConceptScore W1994296072C29730261 @default.
- W1994296072 hasConceptScore W1994296072C71924100 @default.
- W1994296072 hasConceptScore W1994296072C87355193 @default.
- W1994296072 hasConceptScore W1994296072C90924648 @default.
- W1994296072 hasIssue "6" @default.
- W1994296072 hasLocation W19942960721 @default.
- W1994296072 hasLocation W19942960722 @default.
- W1994296072 hasOpenAccess W1994296072 @default.
- W1994296072 hasPrimaryLocation W19942960721 @default.
- W1994296072 hasRelatedWork W174073596 @default.
- W1994296072 hasRelatedWork W1994296072 @default.
- W1994296072 hasRelatedWork W2023165433 @default.
- W1994296072 hasRelatedWork W2033003810 @default.
- W1994296072 hasRelatedWork W2138573355 @default.
- W1994296072 hasRelatedWork W2139550043 @default.
- W1994296072 hasRelatedWork W2336457004 @default.
- W1994296072 hasRelatedWork W2357097748 @default.
- W1994296072 hasRelatedWork W311359282 @default.
- W1994296072 hasRelatedWork W4241272925 @default.
- W1994296072 hasVolume "14" @default.
- W1994296072 isParatext "false" @default.
- W1994296072 isRetracted "false" @default.
- W1994296072 magId "1994296072" @default.
- W1994296072 workType "article" @default.